Annaliese Tisseverasinghe, MD, FRCPC, MSc
- Co-investigator and founding member, Immune Related Adverse Events Associated with the Use of Immune Checkpoint inhibitors: The Canadian Experience (CanRIO)
- Co-investigator and member, Canadian Inflammatory Myopathy Study (CIMS)
- Physician member and contributor, Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS)
- Contributor, Canadian Early Arthritis Cohort (CATCH) and the Manitoba Early Arthritis Cohort
Dr. Tisseverasinghe’s research is aimed at improving clinical outcomes in patients with rheumatic disease by addressing all aspects of health and wellness, including socioeconomic factors and psychiatric and cardiovascular comorbidity. She also has an interest in uncommon or emerging autoimmune diseases and optimizing use of observational data to help inform their management.
She is currently conducting a multidisciplinary project evaluating psychosocial factors impacting lupus disease activity, supported by an operating grant from Health Sciences Centre Foundation. She supervises a number of trainee projects, including a study of polypharmacy and potentially inappropriate medications, such as opioids, in patients with lupus.
Dr. Annaliese Tisseverasinghe obtained her medical degree from Queen’s University, with several medical school honours. After an internal medicine residency at McGill University, she completed a rheumatology fellowship and a masters of clinical epidemiology at the University of Toronto. Prior to medical training, she completed an honours bachelor of science degree in human biology and mathematics at the University of Toronto, graduating with high distinction.
The majority of her time is devoted to patient care in rheumatology clinics, with a special interest in lupus, myositis, and autoimmune disease related to cancer immunotherapy. In addition to rheumatology consult service, she also attends on the g6eneral internal medicine (GIM) clinical teaching unit (CTU) several months a year.
Dr. Tisseverasinghe is a clinical researcher who is actively involved in numerous multidisciplinary and collaborative research projects. She has an interest in psychosocial factors contributing to clinical outcomes and currently holds an HSC foundation grant to study the association between adverse life experiences and lupus disease activity. She is a member of several national rheumatology research groups aimed at advancing the study of rare/emerging autoimmune diseases, including CIMS and CanRIO, for which she is the Manitoba Lead. Dr. Tisseverasinghe also supervises and mentors medical students and residents in their research endeavours. She collaborates in all research within the section of rheumatology, including CaNIOS (lupus), CATCH and ERA (inflammatory arthritis) cohorts, by helping with patient recruitment, data collection, and reviewing abstracts and manuscripts.
Dr. Tisseverasinghe plays an important role in medical education. As a member of the Rheumatology Program Committee, she participates in the teaching, supervision, and mentorship of rheumatology residents. She created the clinical epidemiology curriculum for rheumatology residents, which she organizes and teaches along with pediatric rheumatologist, Dr. Lily Lim. As supervisor of rotating residents, she co-ordinates the schedules, teaching, and evaluation of off-service (e.g. GIM, physiatry, ophthalmology, and family medicine) residents on rheumatology clinics and consult service. In addition to formal lectures at GIM academic half day, she provides informal teaching to trainees while attending on the CTU. She also contributes to undergraduate medical education, including case-based rounds and joint aspiration and injection training.
- Master of Science, Clinical Epidemiology, IHPME, University of Toronto (2016)
- FRCPC, Rheumatology Residency, University of Toronto (2013)
- FRCPC, Internal Medicine Residency, McGill University (2010)
- Medical Doctorate (MD), Queens University (2006)
- Bachelor of Science (Hons.), Human Biology Specialist, Minor in Mathematics (graduated with high distinction), University of Toronto (2002)
Visit Annaliese Tisseverasinghe's ORCID profile for a complete listing.